HCWB

HCW Biologics Inc

Sep 17 • 04:00PM ET

4.31

+0.16 3.86 %

Healthcare • Biotechnology • USA • NASD

Peers: LGND AUPH BYSI IVA FATE ARDX GERN CRBP TVRD CBIO

Index	-	P/E	-	EPS (ttm)	-16.07	Insider Own	24.25%	Shs Outstand	2.15M	Perf Week	28.66%
Market Cap	9.27M	Forward P/E	-	EPS next Y	-4.13	Insider Trans	34.34%	Shs Float	1.63M	Perf Month	7.21%
Enterprise Value	15.37M	PEG	-	EPS next Q	1.58	Inst Own	1.00%	Short Float	15.05%	Perf Quarter	-18.68%
Income	-21.55M	P/S	11.17	EPS this Y	91.82%	Inst Trans	0.13%	Short Ratio	0.13	Perf Half Y	-66.84%
Sales	0.83M	P/B	-	EPS next Y	-63.89%	ROA	-77.35%	Short Interest	0.25M	Perf YTD	-75.85%
Book/sh	-0.02	P/C	3.80	EPS next 5Y	57.65%	ROE	-27725.80%	52W High	100.80 -95.72%	Perf Year	-82.34%
Cash/sh	1.13	P/FCF	-	EPS past 3/5Y	-29.11% -29.55%	ROIC	-1044.52%	52W Low	2.77 55.60%	Perf 3Y	-95.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-162.73%	Volatility	14.95% 15.16%	Perf 5Y	-
Dividend TTM	-	EV/Sales	18.52	EPS Y/Y TTM	61.33%	Oper. Margin	-1534.31%	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.11	Sales Y/Y TTM	-78.77%	Profit Margin	-2588.00%	RSI (14)	48.64	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.11	EPS Q/Q	58.00%	SMA20	-5.30%	Beta	0.67	Target Price	35.00
Payout	-	Debt/Eq	-	Sales Q/Q	-98.94%	SMA50	-2.79%	Rel Volume	0.09	Prev Close	4.15
Employees	36	LT Debt/Eq	-	Earnings	Aug 18 BMO	SMA200	-55.93%	Avg Volume	1.95M	Price	4.31
IPO	Jul 20, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-477.22% -99.98%	Trades		Volume	166,216	Change	3.86%

Sep-16-25 08:00AM	HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development (GlobeNewswire) -15.31%
Sep-09-25 08:00AM	HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program (GlobeNewswire) -6.82%
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +60.82%
08:00AM	HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market (GlobeNewswire)
Aug-18-25 02:44PM	HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results (GlobeNewswire)
07:45AM	Loading…
Jun-27-25 07:45AM	HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors (GlobeNewswire) +6.64%
Jun-26-25 07:55AM	HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements (GlobeNewswire) -5.17%
Jun-04-25 08:20AM	HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech (GlobeNewswire) -8.36%
May-15-25 06:14PM	HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results (GlobeNewswire) -6.92% +9.15%
May-13-25 08:01PM	HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules (GlobeNewswire) +92.90% -12.34%
08:30AM	HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization (GlobeNewswire)
Apr-01-25 04:35PM	HCW Biologics Announces 1-for-40 Reverse Stock Split (GlobeNewswire)
Mar-28-25 03:30PM	HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results (GlobeNewswire)
Mar-06-25 06:55AM	HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements (GlobeNewswire)
Feb-03-25 07:15AM	HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial (GlobeNewswire) +128.58%
07:00AM	Loading…
Jan-15-25 07:00AM	HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 (GlobeNewswire)
Dec-23-24 08:10AM	HCW Biologics Inc. Received NASDAQ Staff Determination Letter (GlobeNewswire) -11.18%
Nov-20-24 01:55AM	HCW Biologics prices $6.9M registered direct offering at $1.03 per share (TipRanks) -13.89%
Nov-18-24 09:27PM	HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules (GlobeNewswire) +320.91% -11.29%
10:15AM	Why Is Penny Stock HCW Biologics Surging On Monday? (Benzinga)
07:00AM	HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate (GlobeNewswire)
Nov-14-24 04:40PM	HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Aug-23-24 04:30PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction (GlobeNewswire) +11.64% -11.21%
Aug-14-24 04:35PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights (GlobeNewswire) -13.62%
May-15-24 09:53PM	HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024 (InvestorPlace) -5.17%
04:39PM	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Apr-01-24 10:53PM	HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -5.71%
04:10PM	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights (GlobeNewswire)
Nov-14-23 07:00AM	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire) -17.73%
Nov-08-23 07:30AM	Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting (GlobeNewswire)
07:30AM	Loading…
Nov-01-23 07:30AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting (GlobeNewswire) -5.36%
Sep-16-23 11:00AM	Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-14-23 01:27PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com) +5.45%
Sep-09-23 01:00PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-06-23 07:30AM	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 13, 2023 (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
07:00AM	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -8.26%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.42%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research) -8.23%
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research) +6.45%
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-07-23 06:28AM	The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable (Simply Wall St.)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research) -5.22%
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) +12.75%
Jun-22-23 07:05AM	Daily Vickers Top Insider Picks for 06/22/2023 (Argus Research)
Jun-21-23 07:05AM	Daily Vickers Top Insider Picks for 06/21/2023 (Argus Research)
Jun-20-23 06:35AM	Daily Vickers Top Insider Picks for 06/20/2023 (Argus Research)
Jun-15-23 06:38AM	Daily Vickers Top Insider Picks for 06/15/2023 (Argus Research)
Jun-14-23 07:30AM	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders (GlobeNewswire)
06:39AM	Daily Vickers Top Insider Picks for 06/14/2023 (Argus Research)
Jun-13-23 06:37AM	Daily Vickers Top Insider Picks for 06/13/2023 (Argus Research)
Jun-12-23 06:47AM	Daily Vickers Top Insider Picks for 06/12/2023 (Argus Research)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research) -6.05%
May-10-23 06:13AM	HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022) (Simply Wall St.)
May-09-23 07:15AM	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire)
Apr-27-23 07:40AM	HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan (GlobeNewswire)
Apr-13-23 07:15AM	HCW Biologics Poster Presentation at AACR Annual Meeting 2023 (GlobeNewswire)
Apr-03-23 08:13AM	A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases (GlobeNewswire)
Mar-28-23 04:25PM	HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +9.77%
Feb-13-23 05:21AM	Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year (Simply Wall St.)
Jan-03-23 07:50AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago (Simply Wall St.)
Dec-08-22 07:55AM	HCW Biologics Enters CRADA with National Cancer Institute (GlobeNewswire)
Dec-07-22 07:30AM	HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI Platform (GlobeNewswire)
Nov-08-22 07:00AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting (GlobeNewswire)
Nov-07-22 04:45PM	HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire)
Aug-28-22 08:06AM	Trade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Shares (Simply Wall St.)
Aug-12-22 07:00AM	HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire) +7.98%
Aug-03-22 07:15AM	U.S. Patent Issued to HCW Biologics for Foundational Platform Technology (GlobeNewswire)
Jul-27-22 07:56AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year ago (Simply Wall St.)
Jun-27-22 06:27AM	Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth (Simply Wall St.)
May-23-22 07:30AM	HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 25, 2022 (GlobeNewswire)
May-13-22 07:15AM	HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
May-05-22 07:30AM	HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI Platform At the 105th Annual Meeting of the American Association of Immunologists (GlobeNewswire)
Apr-19-22 07:33AM	HCW Biologics CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022 (GlobeNewswire)

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wong Hing C	Chief Executive Officer	May 16 '25	Buy	7.45	8,054	60,002	501,911	May 20 04:35 PM
Winer Gary M	Director	May 16 '25	Buy	7.45	1,342	9,998	4,075	May 20 04:35 PM
GARRETT SCOTT T	Director	May 16 '25	Buy	7.45	13,423	100,001	25,505	May 20 04:34 PM
Winer Gary M	Director	May 08 '25	Buy	26.00	2,308	60,008	2,733	May 09 05:33 PM
Wong Hing C	Chief Executive Officer	May 08 '25	Buy	26.00	92,500	2,405,000	493,857	May 09 05:32 PM
GARRETT SCOTT T	Director	May 08 '25	Buy	26.00	5,385	140,010	12,082	May 09 05:31 PM
Byam Rebecca	Chief Financial Officer	May 08 '25	Buy	26.00	8,462	220,012	43,010	May 09 05:30 PM
Flowers Lee	SVP of Business Development	May 08 '25	Buy	26.00	962	25,012	5,720	May 09 05:29 PM
Greene Rick S.	Director	May 08 '25	Buy	26.00	962	25,012	2,066	May 09 05:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HCWB

HCW Biologics Inc

Upgrade your FINVIZ experience